CoStim Pharmaceuticals Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$82.3M
CoStim Pharmaceuticals General Information
Description
Developer of cancer immunotherapy. The company develops antibody drugs targeting immunological checkpoint control.
Contact Information
Corporate Office
- 200 Clarendon Street
- 54th Floor
- Boston, MA 02116
- United States
Corporate Office
- 200 Clarendon Street
- 54th Floor
- Boston, MA 02116
- United States
CoStim Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 11-Jan-2024 | $82.3M | Completed | Generating Revenue | ||
| 4. Merger/Acquisition | 17-Feb-2014 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 23-Dec-2013 | Completed | Product Development | |||
| 2. Early Stage VC (Series A) | 29-Mar-2013 | $10M | $10.7M | Completed | Product Development | |
| 1. Early Stage VC | 01-May-2012 | $700K | $700K | Completed | Generating Revenue |
CoStim Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A2 |
CoStim Pharmaceuticals Comparisons
Industry
Financing
Details
CoStim Pharmaceuticals Competitors (38)
One of CoStim Pharmaceuticals’s 38 competitors is Amgen, a Formerly PE-Backed company based in Thousand Oaks, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Amgen | Formerly PE-Backed | Thousand Oaks, CA | ||||
| Compass Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Filana Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Ionis Pharmaceuticals | Corporate Backed or Acquired | Carlsbad, CA |
CoStim Pharmaceuticals Patents
CoStim Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3049442-A1 | Methods for treating hematologic cancers | Inactive | 26-Sep-2013 | ||
| EP-3049442-A4 | Methods for treating hematologic cancers | Inactive | 26-Sep-2013 | ||
| EP-3757130-A1 | Methods for treating hematologic cancers | Pending | 26-Sep-2013 | ||
| WO-2015048312-A1 | Methods for treating hematologic cancers | Inactive | 26-Sep-2013 | C07K16/2827 |
CoStim Pharmaceuticals Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas Venture | Venture Capital | Minority | ||
| Curative Ventures | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| MPM BioImpact | Venture Capital | Minority | ||
| Mass General Brigham Ventures | Venture Capital | Minority |
CoStim Pharmaceuticals FAQs
-
When was CoStim Pharmaceuticals founded?
CoStim Pharmaceuticals was founded in 2012.
-
Where is CoStim Pharmaceuticals headquartered?
CoStim Pharmaceuticals is headquartered in Boston, MA.
-
What industry is CoStim Pharmaceuticals in?
CoStim Pharmaceuticals’s primary industry is Drug Delivery.
-
Is CoStim Pharmaceuticals a private or public company?
CoStim Pharmaceuticals is a Private company.
-
What is the current valuation of CoStim Pharmaceuticals?
The current valuation of CoStim Pharmaceuticals is .
-
What is CoStim Pharmaceuticals’s current revenue?
The current revenue for CoStim Pharmaceuticals is .
-
How much funding has CoStim Pharmaceuticals raised over time?
CoStim Pharmaceuticals has raised $10.7M.
-
Who are CoStim Pharmaceuticals’s investors?
Atlas Venture, Curative Ventures, Johnson & Johnson JJDC, MPM BioImpact, and Mass General Brigham Ventures have invested in CoStim Pharmaceuticals.
-
Who are CoStim Pharmaceuticals’s competitors?
Amgen, Compass Therapeutics, Filana Therapeutics, Regenxbio, and Ionis Pharmaceuticals are some of the 38 competitors of CoStim Pharmaceuticals.
-
When was CoStim Pharmaceuticals acquired?
CoStim Pharmaceuticals was acquired on 11-Jan-2024.
-
Who acquired CoStim Pharmaceuticals?
CoStim Pharmaceuticals was acquired by Polifin S.R.L. and Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process